Glostrup, Denmark

Dorte Strøbaek

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Saniona A/s. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dorte Strøbaek. Retrieved from https://idiyas.com/inventor/dorte-strøbaek-6w3tnwn5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dorte Strøbaek: Innovator in Potassium Channel Inhibitors

Introduction

Dorte Strøbaek is a prominent inventor based in Glostrup, Denmark. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of potassium channel inhibitors. With a total of 2 patents, her work is pivotal in addressing various diseases related to potassium channel activity.

Latest Patents

Dorte's latest patents focus on novel compounds and pharmaceutical compositions that serve as potassium channel inhibitors. These inventions aim to treat, alleviate, or prevent diseases and disorders associated with the activity of potassium channels. Her innovative approach has the potential to lead to new therapeutic options for patients suffering from related conditions.

Career Highlights

Dorte Strøbaek has established herself as a key figure in her field through her work at Saniona A/S. Her expertise and dedication to research have positioned her as a valuable asset in the pharmaceutical industry.

Collaborations

Dorte collaborates with David Tristram Brown, further enhancing her research capabilities and expanding the impact of her inventions.

Conclusion

Dorte Strøbaek's contributions to the development of potassium channel inhibitors highlight her role as an influential inventor in the pharmaceutical sector. Her work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…